Mice injected with spinal fluid from ALS patients offer potential therapeutic target

By The Science Advisory Board staff writers

August 23, 2022 -- Researchers at the Tisch MS Research Center of New York have shown in a novel animal model that by injecting mice with cerebrospinal fluid (CSF) from patients with the most common form of amyotrophic lateral sclerosis (ALS) they induced permanent motor disability associated with the pathological features of this aggressive and fatal chronic disease.

Their findings, published August 22 in the journal Brain Communications, suggest that an unlikely protein -- apolipoprotein B-100 -- is the culprit behind the kind of neurological degeneration that is a hallmark of ALS.

The paper seems to provide initial proof that filtering apolipoprotein B-100 out of CSF could improve symptoms of sporadic ALS, which occurs at random with no clearly associated risk factors and no family history of the disease.

"This study presents apolipoprotein B-100 as a novel therapeutic target specific for the predominant sporadic form of amyotrophic lateral sclerosis and establishes proof-of-concept to support CSF pheresis as a therapeutic strategy for mitigating neurotoxicity in sporadic amyotrophic lateral sclerosis," the study's authors state.

Repurposed drug shows promise in animal studies as potential therapy for ALS
A drug used to treat enlarged prostates and high blood pressure could help to slow the progression of motor neuron disease, which is also known as amyotrophic...
Gene therapy shows promise in treating ALS in rodent models
A gene therapy, patented through the University of California, San Diego and the Department of Veterans Affairs measurably delayed disease onset in humanized...
Insilico Med, 4B Tech partner on neurodegenerative drug discovery
Insilico Medicine is collaborating with 4B Technologies to develop small-molecule therapies for amyotrophic lateral sclerosis and other major neurological...

Copyright © 2022 scienceboard.net


Conferences
Laboratory Products Association Annual Meeting
October 1-4
Scottsdale, Arizona United States
Cell & Gene Meeting on the Mesa
October 11-13
Carlsbad, California United States
IDWeek 2022
October 19-23
District of Columbia United States
American Society of Human Genetics Annual Meeting
October 25-29
Los Angeles, California United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter